Brief: Kancera Terminates Letter Of Intent With Recardio
12/08/2025 07:04
Aug 12 (Reuters) - Kancera AB KANC.ST: KANCERA TERMINATES LETTER OF INTENT WITH RECARDIO Source text: ID:nMFN36CY6j Further company coverage: KANC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing